390 related articles for article (PubMed ID: 27638713)
21. Gene therapy for Parkinson's disease.
Mochizuki H
Expert Rev Neurother; 2007 Aug; 7(8):957-60. PubMed ID: 17678490
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
[TBL] [Abstract][Full Text] [Related]
23. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
Park JS; Davis RL; Sue CM
Curr Neurol Neurosci Rep; 2018 Apr; 18(5):21. PubMed ID: 29616350
[TBL] [Abstract][Full Text] [Related]
25. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
26. [Animal models for familial Parkinson's disease].
Takahashi R
Rinsho Shinkeigaku; 2007 Nov; 47(11):938-40. PubMed ID: 18210841
[TBL] [Abstract][Full Text] [Related]
27. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
Chen L; Xie Z; Turkson S; Zhuang X
J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
[TBL] [Abstract][Full Text] [Related]
28. Genetic mutations and functions of PINK1.
Kawajiri S; Saiki S; Sato S; Hattori N
Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
[TBL] [Abstract][Full Text] [Related]
29. Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.
Bertolin G; Jacoupy M; Traver S; Ferrando-Miguel R; Saint Georges T; Grenier K; Ardila-Osorio H; Muriel MP; Takahashi H; Lees AJ; Gautier C; Guedin D; Coge F; Fon EA; Brice A; Corti O
Cell Death Differ; 2015 Oct; 22(10):1563-76. PubMed ID: 25591737
[TBL] [Abstract][Full Text] [Related]
30. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease.
Xie W; Wan OW; Chung KK
Biochim Biophys Acta; 2010 Nov; 1802(11):935-41. PubMed ID: 20674742
[TBL] [Abstract][Full Text] [Related]
31. [The role of JNK pathway in familial Parkinson's disease].
Jankowski M
Postepy Biochem; 2007; 53(3):297-303. PubMed ID: 18399358
[TBL] [Abstract][Full Text] [Related]
32. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1).
Kim J; Fiesel FC; Belmonte KC; Hudec R; Wang WX; Kim C; Nelson PT; Springer W; Kim J
Mol Neurodegener; 2016 Jul; 11(1):55. PubMed ID: 27456084
[TBL] [Abstract][Full Text] [Related]
33. Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease.
Yamada M; Mizuno Y; Mochizuki H
Hum Gene Ther; 2005 Feb; 16(2):262-70. PubMed ID: 15761265
[TBL] [Abstract][Full Text] [Related]
34. Parkinson disease: from pathology to molecular disease mechanisms.
Dexter DT; Jenner P
Free Radic Biol Med; 2013 Sep; 62():132-144. PubMed ID: 23380027
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.
Rasheed MZ; Tabassum H; Parvez S
Protoplasma; 2017 Jan; 254(1):33-42. PubMed ID: 26825389
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial dysfunction and Parkinson's disease genes: insights from Drosophila.
Park J; Kim Y; Chung J
Dis Model Mech; 2009; 2(7-8):336-40. PubMed ID: 19553694
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria: A Therapeutic Target for Parkinson's Disease?
Luo Y; Hoffer A; Hoffer B; Qi X
Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial respiratory chain disorganization in Parkinson's disease-relevant PINK1 and DJ1 mutants.
Lopez-Fabuel I; Martin-Martin L; Resch-Beusher M; Azkona G; Sanchez-Pernaute R; Bolaños JP
Neurochem Int; 2017 Oct; 109():101-105. PubMed ID: 28408307
[TBL] [Abstract][Full Text] [Related]
39. The endoplasmic reticulum/mitochondria interface: a subcellular platform for the orchestration of the functions of the PINK1-Parkin pathway?
Erpapazoglou Z; Corti O
Biochem Soc Trans; 2015 Apr; 43(2):297-301. PubMed ID: 25849933
[TBL] [Abstract][Full Text] [Related]
40. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
